Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

Journal total citations count 2004
Journal impact factor 5.32
Journal 5 years impact factor 5.62
Journal cite score 5.3
Journal h-index 22
Journal h-index since 2019 17
Important citations (1101)

Novel ?-coronavirus (sars-cov-2): current and future aspects of pharmacological treatments.

The spectrum of antibiotic prescribing during covid-19 pandemic: a systematic literature review

Therapeutic options for coronavirus disease 2019 (covid-19) - modulation of type i interferon response as a promising strategy?

what the dental practitioner needs to know about pharmaco-therapeutic modalities of covid-19 treatment: a review.

therapeutic options for covid-19: a quick review.

Azithromycin, a questionable treatment for covid-19

Use of hydroxychloroquine and chloroquine in patients with covid-19: a meta-analysis of randomized clinical trials.

insights of severe acute respiratory syndrome coronavirus (sars-cov-2) pandemic: a current review

Inhibitory capacity of chloroquine against sars-cov-2 by effective binding with angiotensin converting enzyme-2 receptor: an insight from molecular docking and md-simulation studies

Study of the structural, chemical descriptors and optoelectronic properties of the drugs hydroxychloroquine and azithromycin

Repurposing drugs for treatment of sars-cov-2 infection: computational design insights into mechanisms of action.

Antimalarial and cytotoxic drugs on covid-19 and the cardiovascular burden: literature review and lessons to be learned

erythromycin estolate inhibits zika virus infection by blocking viral entry as a viral inactivator

recent progress in the repurposing of drugs/molecules for the management of covid-19

Covid-19 and therapeutic drugs repurposing in hand: the need for collaborative efforts

in silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against sars-cov-2 infection.

review of pharmacologic and immunologic agents in the management of covid-19.

Potential anti-covid-19 therapeutics that block the early stage of the viral life cycle: structures, mechanisms, and clinical trials

effective drugs used to combat sars-cov-2 infection and the current status of vaccines.

Sars-cov-2: pathogenesis, and advancements in diagnostics and treatment.

Top